# Resveratrol Insulin Sensitivity Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/resveratrol-insulin-sensitivity-meta-analysis-evidence-review
Category: evidence-review
Summary: Resveratrol Insulin Sensitivity Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pa
Last reviewed: 2026-06-24
Reviewed by: Migaku Evidence Review
# Resveratrol Insulin Sensitivity Meta-analysis: What the Evidence Says

## Quick Answer

Resveratrol Insulin Sensitivity Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review. | systematic review | 1 | 2026-05-26 | 10.3390/molecules31111837 |
| Resveratrol in diabetes and pancreatic function: implications for the exocrine–endocrine pancreatic axis–a systematic review | systematic review | 1 | 2026-04-22 | 10.3389/fnut.2026.1806881 |

## What The Sources Report

- The main aim of this systematic review is to comprehensively evaluate and synthesize the current scientific evidence on the role of anthocyanins, curcumin, and resveratrol in the prevention and management of metabolic disorders, with a focus on obesity, type 2 diabetes, and dyslipidemia. [Gazda P (2026); evidence level 1]
- The analyzed studies demonstrated that anthocyanin supplementation (up to 320 mg/day) was associated with reductions in inflammatory markers such as IL-6 and TNF-α, improvements in HDL cholesterol, and modest reductions in HbA1c (~0.3-0.5%). [Gazda P (2026); evidence level 1]
- Resveratrol is a naturally occurring polyphenolic compound found in various plants, including grapes, berries, and peanuts. [Meden Ana (2026); evidence level 1]
- However, most available evidence originates from studies focusing on metabolic forms of diabetes rather than pancreatic disease-related diabetes (,-). [Meden Ana (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For resveratrol insulin sensitivity meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Gazda P (2026). The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review.. DOI: 10.3390/molecules31111837. PMCID: PMC13258050. PMID: 42280140. https://pmc.ncbi.nlm.nih.gov/articles/PMC13258050/
- Meden Ana (2026). Resveratrol in diabetes and pancreatic function: implications for the exocrine–endocrine pancreatic axis–a systematic review. DOI: 10.3389/fnut.2026.1806881. PMCID: PMC13144009. PMID: 42099770. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13144009/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.